ArticleOncoimmunology2022

Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models.

S Elizabeth Franks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.